Pathway-Specific, Species, and Sub-Type Counterscreening for Better GPCR Hits in High Throughput Screening

Publisher： Bentham Science Publishers

E-ISSN： 1873-4316|11|7|757-763

ISSN： 1389-2010

Source： Current Pharmaceutical Biotechnology, Vol.11, Iss.7, 2010-11, pp. : 757-763

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Species and pathway-specific activation of complement by a phosphorothioate oligonucleotide

By Henry S.   Jagels M.   Hugli T.   Giclas P.  

Immunopharmacology, Vol. 49, Iss. 1, 2000-08 ,pp. : 97-97

Elsevier

Access to resources Recommend Favorite

Identification and Validation of Hits from High Throughput Screens for CFTR Modulators

By  

Current Pharmaceutical Design, Vol. 18, Iss. 5, 2012-02 ,pp. : 628-641

Bentham Science Publishers

Access to resources Recommend Favorite

Technological Advances in High-Throughput Screening

By Bailing Liu   Songjun Li   Jie Hu  

American Journal of PharmacoGenomics, Vol. 4, Iss. 4, 2004-01 ,pp. : 263-276

Adis International

Access to resources Recommend Favorite

Network Medicine and High Throughput Screening

By  

Current Drug Discovery Technologies, Vol. 10, Iss. 3, 2013-09 ,pp. : 182-194

Bentham Science Publishers

Access to resources Recommend Favorite

Non-stoichiometric inhibition in biochemical high-throughput screening

By Coan Kristin ED   Ottl Johannes   Klumpp Martin  

Expert Opinion on Drug Discovery, Vol. 6, Iss. 4, 2011-04 ,pp. : 405-417

Informa Healthcare

Access to resources Recommend Favorite